Publications

• Development of a Structured Management Plan and Educational Materials for a Multidisciplinary Pediatric Menstrual Bleeding Disorder Clinic.
  J Dr Nurs Pract
  04/10/2025 Authors: Tickle K; Hartley P; Langley-Brady D; Joshua T; Sidonio RF; Brown M; Gettis M; Cherven B
• Bone Health Screening in Persons With Bleeding Disorders: A Survey of United States Haemophilia Treatment Centres.
  Haemophilia
  03/07/2025 Authors: Citla-Sridhar D; Ahuja S; Sidonio R; Chitlur M; Sharathkumar A; Tobase P; Acharya S; Isaac D; Kulkarni R; Johnson MM
• Etiology and diagnosis of heavy menstrual bleeding among adolescent and adult patients: a systematic review and meta-analysis of the literature.
  J Thromb Haemost Volume: 23 Page(s): 863 - 876
  03/01/2025 Authors: Comishen KJ; Bhatt M; Yeung K; Irfan J; Zia A; Sidonio RF; James P
• Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease - WIL-31 study post hoc analysis.
  Res Pract Thromb Haemost Volume: 9 Page(s): 102719
  02/01/2025 Authors: Sidonio RF; Dubey L; Vilchevska KV; Inati A; Djambas Khayat C
• Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.
  J Thromb Haemost Volume: 23 Page(s): 651 - 656
  02/01/2025 Authors: Goldenberg NA; Schulman S; Kittelson JM; Abshire TC; Casella JF; Dale R; Halperin JL; Hanson J; Kessler CM; Manco-Johnson MJ
• Real-world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi-institutional case series.
  Haemophilia Volume: 30 Page(s): 1321 - 1331
  11/01/2024 Authors: Youkhana K; Batsuli G; Acharya S; Khan O; Tran DQ; Dvorak A; Recht M; Young G; Sidonio R; Abajas Y
• Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what's new on the horizon?
  Expert Opin Pharmacother Volume: 25 Page(s): 1427 - 1438
  08/01/2024 Authors: Regling K; Sidonio RF
• Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH.
  J Thromb Haemost Volume: 22 Page(s): 2059 - 2070
  07/01/2024 Authors: Baker RI; Choi P; Curry N; Gebhart J; Gomez K; Henskens Y; Heubel-Moenen F; James P; Kadir RA; Kouides P
• Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A.
  Haemophilia Volume: 30 Page(s): 905 - 913
  07/01/2024 Authors: Agarwal S; Hermans C; Miesbach W; Peyvandi F; Sidonio R; Osmond D; Newman V; Henshaw J; Pipe S
• Nanobody activator improves sensitivity of the von Willebrand factor activity assay to multimer size.
  J Thromb Haemost Volume: 22 Page(s): 2052 - 2058
  07/01/2024 Authors: Liang Q; Parker ET; Dean G; Karpen MS; Wu Y; Wang X; Di Paola J; Maier CL; Meeks SL; Lollar P
• Early diagnosis of persons with von Willebrand disease using a machine learning algorithm and real-world data.
  Expert Rev Hematol Volume: 17 Page(s): 261 - 268
  06/01/2024 Authors: Sidonio RF; Lu A; Hale S; Caicedo J; Bullano M; Xing S
• Adequate menstrual suppression in adolescents with inherited bleeding disorders often requires multiple treatment changes: Retrospective cohort study of a multidisciplinary clinic.
  Pediatr Blood Cancer Volume: 71 Page(s): e30944
  06/01/2024 Authors: Brown MC; Tickle K; Woods K; Sidonio RF
• RNAing toward a new therapy for hemophilia.
  Blood Volume: 143 Page(s): 2219 - 2221
  05/30/2024 Authors: Doshi BS; Sidonio RF
• Conformational activation and inhibition of von Willebrand factor by targeting its autoinhibitory module.
  Blood Volume: 143 Page(s): 1992 - 2004
  05/09/2024 Authors: Arce NA; Markham-Lee Z; Liang Q; Najmudin S; Legan ER; Dean G; Su AJ; Wilson MS; Sidonio RF; Lollar P
• Unresolved hemostasis issues in haemophilia.
  Haemophilia Volume: 30 Suppl 3 Page(s): 70 - 77
  04/01/2024 Authors: Sidonio RF; Weisel JW; Stafford D
• von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease.
  Blood Adv Volume: 8 Page(s): 1405 - 1414
  03/26/2024 Authors: Sidonio RF; Boban A; Dubey L; Inati A; Kiss C; Boda Z; Lissitchkov T; Nemes L; Novik D; Peteva E
• Procedural outcomes in children with mild type 1 von Willebrand disease.
  Res Pract Thromb Haemost Volume: 8 Page(s): 102334
  01/01/2024 Authors: Heery S; Zimowski K; Mason SF; White MH; DiGiandomenico S; Trotter C; Sidonio RF; Brown MC
• Simoctocog alfa (Nuwiq) in children: early steps in life's journey for people with severe hemophilia A.
  Ther Adv Hematol Volume: 15 Page(s): 20406207241245511
  01/01/2024 Authors: Klukowska A; Sidonio RF; Young G; Mancuso ME; lvarez-Romn MT; Bhatnagar N; Jansen M; Knaub S
• Efficacy of Wilate Prophylaxis in Reducing Nosebleeds in Patients with Severe VWD - A Post-hoc Analysis of the WIL-31 Study.
  Clin Appl Thromb Hemost Volume: 30 Page(s): 10760296241306755
  01/01/2024 Authors: Boban A; Dubey L; Vilchevska KV; Inati A; Khayat CD; Sidonio RF
• Assessment of menstrual health in adolescent and young adults with sickle cell disease.
  Pediatr Blood Cancer Volume: 71 Page(s): e30727
  01/01/2024 Authors: Notice B; Soffer E; Tickle K; Xiang Y; Gee BE; Sidonio RF; Sokkary N; Batsuli G
• Patient-centred research agendafor females with bleeding disorders.
  Haemophilia Volume: 29 Page(s): 1665 - 1667
  11/01/2023 Authors: Crescioni M; Armijo W; Chupka J; Tarver D; Sidonio R; Brown MC; Haley KM; Huguelet P; Bowe-Hause K; Conde J
• Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real-world retrospective multi-institutional cohort.
  Am J Hematol Volume: 98 Page(s): E285 - E287
  10/01/2023 Authors: Batsuli G; Wheeler AP; Weyand AC; Sidonio RF; Young G
• Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.
  Lancet Haematol Volume: 10 Page(s): e612 - e623
  08/01/2023 Authors: Ragni MV; Rothenberger SD; Feldman R; Nance D; Leavitt AD; Malec L; Kulkarni R; Sidonio R; Kraut E; Lasky J
• Von Willebrand Disease: Gaining a global perspective.
  Haemophilia Volume: 29 Page(s): 1104 - 1112
  07/01/2023 Authors: O'Sullivan JM; Tootoonchian E; Ziemele B; Makris M; Federici AB; Khayat Djambas C; El Ekiaby M; Rotellini D; Sidonio RF; Iorio A
• Reproductive healthcare utilization in patients with bleeding disorders.
  J Thromb Haemost Volume: 21 Page(s): 1741 - 1743
  07/01/2023 Authors: Citla-Sridhar D; Sidonio RF; Ahuja S
• USE OF CAPLACIZUMAB IN PEDIATRIC THROMBOTIC THROMBOCYTOPENIC PURPURA PATIENTS
  Volume: 70 Page(s): S139 - S139
  06/01/2023 Authors: Graciaa S; Sidonio R; Zerra P; Rollins M; Briones M; Chonat S
• Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders.
  Expert Rev Hematol Volume: 16 Page(s): 39 - 54
  03/01/2023 Authors: Sidonio RF; Bryant PC; Di Paola J; Hale S; Heiman M; Horowitz GS; Humphrey C; Jaffray J; Joyner LC; Kasthuri R
• Depression and anxiety in persons with Von Willebrand disease.
  Haemophilia Volume: 29 Page(s): 545 - 554
  03/01/2023 Authors: Roberts JC; Kulkarni R; Kouides PA; Sidonio RF; Carpenter SL; Konkle BA; Wu J; Ullman MM; Curtis R; Baker JR
• The emotional experience of mothers of children with haemophilia: maternal guilt, effective coping strategies and resilience within the haemophilia community.
  Haemophilia Volume: 29 Page(s): 513 - 520
  03/01/2023 Authors: Sheridan N; Thompson B; Lichten L; Coleman K; Sidonio R
• Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study.
  Expert Rev Hematol Volume: 16 Page(s): 793 - 801
  01/01/2023 Authors: Sidonio RF; Thompson AA; Peyvandi F; Stasyshyn O; Yeoh SL; Sosothikul D; Antmen AB; Maggiore C; Engl W; Ewenstein B
• Emicizumab dose up-titration in case of suboptimal bleeding control in people with haemophilia A.
  Haemophilia Volume: 29 Page(s): 90 - 99
  01/01/2023 Authors: Schmitt C; Mancuso ME; Chang T; Podolak-Dawidziak M; Petry C; Sidonio R; Yoneyama K; Key NS; Niggli M; Lehle M
• Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B-LONG trial.
  Haemophilia Volume: 29 Page(s): 404 - 407
  01/01/2023 Authors: Sidonio RF; Casiano S; Falk A; Altincatal A; Katragadda S; Santagostino E; Windyga J
• Thrombin generation and implications for hemophilia therapies: A narrative review.
  Res Pract Thromb Haemost Volume: 7 Page(s): 100018
  01/01/2023 Authors: Sidonio RF; Hoffman M; Kenet G; Dargaud Y
• Diagnostic pitfalls and conundrums in type 1 von Willebrand disease.
  Hematology Am Soc Hematol Educ Program Volume: 2022 Page(s): 618 - 623
  12/09/2022 Authors: Sidonio RF; Lavin M
• Early stage clinical trials for the treatment of hemophilia A.
  Expert Opin Investig Drugs Volume: 31 Page(s): 1169 - 1186
  11/01/2022 Authors: Guzzardo GM; Sidonio R; Callaghan MU; Regling K
• Bone health in haemophilia carriers and persons with von Willebrand disease: A large database analysis.
  Haemophilia Volume: 28 Page(s): 671 - 678
  07/01/2022 Authors: Citla-Sridhar D; Sidonio RF; Ahuja SP
• "A New Hemophilia Carrier Nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH": Reply to comment.
  J Thromb Haemost Volume: 20 Page(s): 1745 - 1746
  07/01/2022 Authors: Sidonio RF
• Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program.
  J Thromb Haemost Volume: 20 Page(s): 1576 - 1588
  07/01/2022 Authors: Christopherson PA; Haberichter SL; Flood VH; Perry CL; Sadler BE; Bellissimo DB; Di Paola J; Montgomery RR; Zimmerman Program Investigators
• CLAIMS-BASED ALGORITHMS TO IDENTIFY PERSONS WITH SEVERE HEMOPHILIA A
  Volume: 25 Page(s): S438 - S439
  07/01/2022 Authors: Khairnar R; Mahajerin A; Shapiro AD; Sidonio R; Okolo A; Decker-Palmer M; Patel A; Gibbs SN; Campos C; Broder M
• Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements.
  J Manag Care Spec Pharm Volume: 28 Page(s): 518 - 527
  05/01/2022 Authors: Alexander WA; Jensen I; Hathway J; Srivastava K; Cyr P; Sidonio RF; Batt K
• Quality of life and outcome improvement in adolescents with bleeding disorders receiving medical management for heavy menstrual bleeding
  Volume: 28 Page(s): 96 - 96
  05/01/2022 Authors: Tickle K; Cherven B; Keesari R; Greene A; White M; Calamaro C; Kumpf P; Sidonio R
• Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues.
  Haemophilia Volume: 28 Suppl 4 Page(s): 18 - 25
  05/01/2022 Authors: Weyand AC; Sidonio RF; Sholzberg M
• Self-reported migraine in subjects with von Willebrand disease
  Volume: 28 Page(s): 92 - 93
  05/01/2022 Authors: MacGregor C; Helm T; Cerasoli F; Boice J; Sidonio R
• The emotional experience of hemophilia heterozygote women: Average maternal guilt, effective coping strategies, and resilience within the hemophilia community
  Volume: 24 Page(s): S359 - S360
  03/21/2022 Authors: Sheridan N; Coleman K; Thompson B; Sidonio R
• Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
  J Cardiothorac Vasc Anesth Volume: 36 Page(s): 724 - 727
  03/01/2022 Authors: Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
• EFFICACY AND SAFETY OF RURIOCTOCOG ALFA PEGOL IN PERIOPERATIVE MANAGEMENT: INTERIM RESULTS FROM AN OPEN-LABEL MULTICENTER CLINICAL TRIAL IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A
  Volume: 28 Page(s): 48 - 48
  02/01/2022 Authors: Peyvandi F; Sidonio RF; Stasyshyn O; Alamelu J; Glosli H; Le P-Q; Albayrak C; Antmen AB; Lopez MF; Maggiore C
• Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations.
  Blood Adv Volume: 6 Page(s): 420 - 428
  01/25/2022 Authors: Sadler B; Minard CG; Haller G; Gurnett CA; O'Brien SH; Wheeler A; Jain S; Sharma M; Zia A; Kulkarni R
• Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
  JAMA Volume: 327 Page(s): 129 - 137
  01/11/2022 Authors: Goldenberg NA; Kittelson JM; Abshire TC; Bonaca M; Casella JF; Dale RA; Halperin JL; Hamblin F; Kessler CM; Manco-Johnson MJ
• von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis.
  Blood Adv Volume: 6 Page(s): 62 - 71
  01/11/2022 Authors: Kalot MA; Husainat N; El Alayli A; Abughanimeh O; Diab O; Tayiem S; Madoukh B; Dimassi AB; Qureini A; Ameer B
• Dental habits and oral health in children and adolescents with bleeding disorders: A single-institution cross-sectional study.
  Volume: 28 Page(s): 73 - 79
  01/01/2022 Authors: Brown MC; Hastie E; Shumake C; Waters B; Sidonio RF
• International consensus recommendations on the management of people with haemophilia B.
  Ther Adv Hematol Volume: 13 Page(s): 20406207221085202
  01/01/2022 Authors: Hart DP; Matino D; Astermark J; Dolan G; d'Oiron R; Hermans C; Jimnez-Yuste V; Linares A; Matsushita T; McRae S
• Managing Severe Hemophilia A in Children: Pharmacotherapeutic Options.
  Pediatric Health Med Ther Volume: 13 Page(s): 27 - 35
  01/01/2022 Authors: Regling K; Callaghan MU; Sidonio R
• Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database.
  Haemophilia Volume: 28 Page(s): 97 - 108
  01/01/2022 Authors: Roberts JC; Malec LM; Halari I; Hale SA; Oladapo A; Sidonio RF
• Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy.
  Blood Adv Volume: 5 Page(s): 5023 - 5031
  12/14/2021 Authors: Kalot MA; Husainat N; Tayiem S; El Alayli A; Dimassi AB; Diab O; Abughanimeh O; Madoukh B; Qureini A; Ameer B
• Hemophilia B (Factor IX Deficiency).
  Hematol Oncol Clin North Am Volume: 35 Page(s): 1143 - 1155
  12/01/2021 Authors: Sidonio RF; Malec L
• The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
  Haemophilia Volume: 27 Page(s): 921 - 931
  11/01/2021 Authors: Escobar M; Castaman G; Boix SB; Callaghan M; de Moerloose P; Ducore J; Hermans C; Journeycake J; Leissinger C; Luck J
• Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States.
  Haemophilia Volume: 27 Page(s): 1037 - 1044
  11/01/2021 Authors: Miller CH; Soucie JM; Byams VR; Payne AB; Sidonio RF; Buckner TW; Bean CJ
• A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH.
  J Thromb Haemost Volume: 19 Page(s): 1883 - 1887
  08/01/2021 Authors: van Galen KPM; d'Oiron R; James P; Abdul-Kadir R; Kouides PA; Kulkarni R; Mahlangu JN; Othman M; Peyvandi F; Rotellini D
• COVID-19 Cliff Notes: A COVID-19 Multidisciplinary Care Compendium.
  Transplant Cell Ther Volume: 27 Page(s): 474.e1 - 474.e3
  06/01/2021 Authors: Williams KM; Wilson PT; Silva-Palacios F; Kebbe J; LaBeaud AD; Agudelo H; Sidonio RF; Stowell SR; Josephson CD; Tarini BA
• Plasma factor IX: The tip of the iceberg?
  Haemophilia Volume: 27 Page(s): 329 - 331
  05/01/2021 Authors: Sidonio RF; Batsuli G
• Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease.
  Res Pract Thromb Haemost Volume: 5 Page(s): e12513
  05/01/2021 Authors: Brown MC; White MH; Friedberg R; Woods K; Childress K; Kulkarni M; Sidonio RF
• Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States.
  Haemophilia Volume: 27 Page(s): 445 - 453
  05/01/2021 Authors: Michael Soucie J; Miller CH; Byams VR; Payne AB; Abe K; Sidonio RF; Kouides PA
• Discussing investigational AAV gene therapy with hemophilia patients: A guide.
  Blood Rev Volume: 47 Page(s): 100759
  05/01/2021 Authors: Sidonio RF; Pipe SW; Callaghan MU; Valentino LA; Monahan PE; Croteau SE
• Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study.
  Orphanet J Rare Dis Volume: 16 Page(s): 189
  04/28/2021 Authors: Hart DP; Branchford BR; Hendry S; Ledniczky R; Sidonio RF; Ngrier C; Kim M; Rice M; Minshall M; Arc C
• Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review.
  Haemophilia Volume: 27 Page(s): 293 - 304
  03/01/2021 Authors: Chaudhury A; Sidonio R; Jain N; Tsao E; Tymoszczuk J; Oviedo Ovando M; Kulkarni R
• Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders.
  Haemophilia Volume: 27 Page(s): 211 - 220
  03/01/2021 Authors: Aquino CC; Borg Debono V; Germini F; Pete D; Kempton CL; Young G; Sidonio R; Croteau SE; Dunn AL; Key NS
• Substitution therapy.
  Haemophilia Volume: 27 Suppl 3 Page(s): 53 - 59
  02/01/2021 Authors: Shima M; Sidonio RF
• CLINICAL OUTCOMES IN PATIENTS WITH HAEMOPHILIA A AFTER SWITCHING TO RURIOCTOCOG ALFA PEGOL PROPHYLAXIS IN THE ATHN 2 STUDY
  Volume: 27 Page(s): 55 - 56
  02/01/2021 Authors: Journeycake J; Caicedo J; Cheng D; Denne M; Guelcher C; Lattimore S; Mokdad A; Ragni M; Recht M; Sidonio R
• FACTOR UTILISATION IN PATIENTS WITH HAEMOPHILIA A AFTER SWITCHING TO RURIOCTOCOG ALFA PEGOL IN THE ATHN 2 STUDY
  Volume: 27 Page(s): 79 - 80
  02/01/2021 Authors: Journeycake J; Caicedo J; Cheng D; Denne M; Guelcher C; Lattimore S; Mokdad A; Ragni M; Recht M; Sidonio R
• Emicizumab in tolerized patients with hemophilia A with inhibitors: A single-institution pediatric cohort assessing inhibitor status.
  Res Pract Thromb Haemost Volume: 5 Page(s): 342 - 348
  02/01/2021 Authors: Batsuli G; Greene A; Meeks SL; Sidonio RF
• von Willebrand disease: proposing definitions for future research.
  Blood Adv Volume: 5 Page(s): 565 - 569
  01/26/2021 Authors: Connell NT; James PD; Brignardello-Petersen R; Abdul-Kadir R; Ameer B; Arapshian A; Couper S; Di Paola J; Eikenboom J; Giraud N
• ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.
  Blood Adv Volume: 5 Page(s): 280 - 300
  01/12/2021 Authors: James PD; Connell NT; Ameer B; Di Paola J; Eikenboom J; Giraud N; Haberichter S; Jacobs-Pratt V; Konkle B; McLintock C
• Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE).
  Ther Adv Hematol Volume: 12 Page(s): 20406207211032452
  01/01/2021 Authors: Escuriola Ettingshausen C; Sidonio RF
• Incidence and Timing of Thrombosis After the Norwood Procedure in the Single-Ventricle Reconstruction Trial.
  J Am Heart Assoc Volume: 9 Page(s): e015882
  12/15/2020 Authors: White MH; Kelleman M; Sidonio RF; Kochilas L; Patel KN
• Dosing, Patient Satisfaction and Other Patient-Reported Outcomes after Switching to Rurioctocog Alfa Pegol in Athn 2: A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Coagulation Replacement Factor Products
  Volume: 136
  11/05/2020 Authors: Journeycake JM; Recht M; Guelcher C; Neufeld EJ; Ragni MV; Sidonio RF; Takemoto C; Tarantino MD; Cheng D; Lattimore SU
• Bleeding in Patients with Clinically Severe Von Willebrand Disease: Preliminary Results of Athn 9, a Natural History Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)
  Volume: 136
  11/05/2020 Authors: Weyand AC; Friedman KD; Gupta S; Haley KM; He C; Pels S; Roberts JC; Watson C; Sidonio RF
• In Vitro Evaluation of Thrombin Generation of Eptacog Beta (Factor VIIa, Recombinant) and Emicizumab in Congenital Hemophilia. Plasma with and without Inhibitors
  Volume: 136
  11/05/2020 Authors: Pipe SW; Recht M; Callaghan MU; Sidonio RF; Grandoni J; Duretz V; Bonzo D; Plantier JL; Evans S; Mitchell IS
• Genotype Analysis of Adolescents with Heavy Menstrual Bleeding and Low Von Willebrand Activity - Report of a Multi-Center Study
  Volume: 136
  11/05/2020 Authors: Sadler B; Minard C; Haller G; Gurnett C; O'Brien SH; Wheeler AP; Mullins ES; Sharma M; Sidonio RF; Jain S
• Health-related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors-Results from the HAVEN 2 study.
  Haemophilia Volume: 26 Page(s): 1009 - 1018
  11/01/2020 Authors: Mancuso ME; Mahlangu J; Sidonio R; Trask P; Uguen M; Chang T; Shima M; Young G; Oldenburg J; von Mackensen S
• Laboratory misdiagnosis of von Willebrand disease in post-menarchal females: A multi-center study.
  Am J Hematol Volume: 95 Page(s): 1022 - 1029
  09/01/2020 Authors: Jaffray J; Staber JM; Malvar J; Sidonio R; Haley KM; Stillings A; Weyand A; Hege K; Jain S; Gupta S
• The impact of extended half-life factor concentrates on prophylaxis for severe hemophilia in the United States.
  Am J Hematol Volume: 95 Page(s): 960 - 965
  08/01/2020 Authors: Malec LM; Cheng D; Witmer CM; Jaffray J; Kouides PA; Haley KM; Sidonio RF; Johnson K; Recht M; White G
• The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding.
  Blood Adv Volume: 4 Page(s): 3209 - 3216
  07/14/2020 Authors: Srivaths L; Minard CG; O'Brien SH; Wheeler AP; Mullins E; Sharma M; Sidonio R; Jain S; Zia A; Ragni MV
• Treatments and clinical outcomes of bleeding related to pregnancy, surgery, or spontaneous or traumatic bleeds in women and girls with factor VIII and IX deficiency: results from a retrospective chart review
  Volume: 26 Page(s): 78 - 79
  06/01/2020 Authors: Chaudhury A; Sidonio R; Jain N; Tsao E; Tymoszczuk J; Ovando MO; Kulkarni R
• Inhibitor status of patients with Hemophilia A who transition to Emicizumab after Immune Tolerance Induction
  Volume: 26 Page(s): 28 - 28
  06/01/2020 Authors: Batsuli G; Greene A; Meeks SL; Sidonio RF
• VON WILLEBRAND STUDIES DURING ACUTE HEAVY MENSTRUAL BLEEDING MAY BE HELPFUL IN DIAGNOSIS OF VWD
  Volume: 67 Page(s): S66 - S66
  06/01/2020 Authors: Brown M; Sidonio R
• A Cross-Sectional Study of Women and Girls with Congenital Bleeding Disorders: The American Thrombosis and Hemostasis Network Cohort.
  J Womens Health (Larchmt) Volume: 29 Page(s): 670 - 676
  05/01/2020 Authors: Haley KM; Sidonio RF; Abraham S; Cheng D; Recht M; Kulkarni R
• Spontaneous bleeding and poor bleeding response with extended half-life factor IX products: A survey of select US haemophilia treatment centres.
  Haemophilia Volume: 26 Page(s): e128 - e129
  05/01/2020 Authors: Malec LM; Croteau SE; Callaghan MU; Sidonio RF
• Characterizing female patients with haemophilia A: Administrative claims analysis and medical chart review.
  Haemophilia Volume: 26 Page(s): 520 - 528
  05/01/2020 Authors: Farej R; Batt K; Afonja O; Martin C; Aubert R; Carlyle M; White J; Sidonio RF
• CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF A VON WILLEBRAND FACTOR FVIII CONCENTRATE (VWF/FVIII) DURING PROPHYLAXIS IN PREVIOUSLY TREATED PATIENTS WITH VON WILLEBRAND DISEASE (VWD)
  Volume: 26 Page(s): 140 - 140
  02/01/2020 Authors: Sidonio R; Dubey L; Timofeeva M; Vilchevska K; Vdovin V; Schmid M; Solomon C; Knaub S
• An international survey to inform priorities for new guidelines on von Willebrand disease.
  Haemophilia Volume: 26 Page(s): 106 - 116
  01/01/2020 Authors: Kalot MA; Al-Khatib M; Connell NT; Flood V; Brignardello-Petersen R; James P; Mustafa RA; VWD working group
• Potential Undiagnosed VWD Or Other Mucocutaneous Bleeding Disorder Cases Estimated From Private Medical Insurance Claims.
  J Blood Med Volume: 11 Page(s): 1 - 11
  01/01/2020 Authors: Sidonio RF; Zia A; Fallaize D
• Awareness, Care and Treatment In Obesity maNagement to inform Haemophilia Obesity Patient Empowerment (ACTION-TO-HOPE): Results of a survey of US haemophilia treatment centre professionals.
  Haemophilia Volume: 26 Suppl 1 Page(s): 20 - 30
  01/01/2020 Authors: Wang M; Peltier S; Baumann K; Sidonio RF; Witkop M; Cooper DL; Waters EK; Kahan S
• A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.
  Blood Volume: 134 Page(s): 2127 - 2138
  12/12/2019 Authors: Young G; Liesner R; Chang T; Sidonio R; Oldenburg J; Jimnez-Yuste V; Mahlangu J; Kruse-Jarres R; Wang M; Uguen M
• Economic impact model of delayed inhibitor development in patients with hemophilia a receiving emicizumab for the prevention of bleeding events.
  J Med Econ Volume: 22 Page(s): 1328 - 1337
  12/01/2019 Authors: Patel AM; Corman SL; Chaplin S; Raimundo K; Sidonio RF
• TFPI blockade: removing coagulation's brakes.
  Blood Volume: 134 Page(s): 1885 - 1887
  11/28/2019 Authors: Sidonio RF; Zimowski KL
• Obtaining a Von Willebrand Evaluation at Time of Acute Heavy Menstrual Bleeding Presentation Leads to Overestimation of Von Willebrand Levels
  Volume: 134
  11/13/2019 Authors: Brown MC; White MH; Sidonio RF
• The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study
  Volume: 134
  11/13/2019 Authors: Jaffray J; Sidonio RF; Malvar J; Staber JM; Haley KM; Stillings A; Weyand AC; O'Brien SH; Kouides PA
• Severe Bleeding Events in Hemophilia. Patients Receiving Emicizumab Prophylaxis
  Volume: 134
  11/13/2019 Authors: Zimowski KL; Batsuli GM; Bryant P; McDaniel J; Tickle K; Meeks SL; Sidonio RF
• Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
  Volume: 134
  11/13/2019 Authors: Ragni MV; Seaman CD; Gilligan D; Philipp CS; Neff AT; Sidonio RF; Kuriakose P; Wang T-F; Malec LM; Pruthi RK
• Thrombotic Outcomes Following Hormonal Treatment of Heavy Menstrual Bleeding in Pediatric Patients Taking Anticoagulation
  Volume: 134
  11/13/2019 Authors: White MH; Woods G; Sidonio RF
• Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study
  Volume: 134
  11/13/2019 Authors: Sidonio RF; Weyand AC; Cheng D; Watson C
• Clinical Study to Investigate the Efficacy and Safety of Wilate during Prophylaxis in Previously Treated Patients with Von Willebrand Disease (VWD)
  Volume: 134
  11/13/2019 Authors: Sidonio RF; Schwartz BA
• Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database
  Volume: 134
  11/13/2019 Authors: Roberts JC; Malec LM; Halari I; Hale S; Oladapo A; Sidonio R
• Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome
  Volume: 134
  11/13/2019 Authors: Sidonio RF; Cheng D; Guelcher C; Journeycake JM; Lattimore SU; Takemoto C; Tarantino MD; Watson C; Neufeld EJ; Fedor C
• COMBINATION OF EMICIZUMAB WITH SIM OCT OCOG ALFA FOR PROPHYLAXIS IN PREVIOUSLY UNTREATED/MINIMALLY TREATED HEMOPHILIA A PATIENTS, AND FOR MANAGING INHIBITOR PATIENTS
  Volume: 104 Page(s): 16 - 17
  09/09/2019 Authors: Sidonio R; Meeks SL; Shapiro A; Manco-Johnson M; Callaghan M
• MOTIVATE: MODERN TREATMENT OF INHIBITOR-POSITIVE PATIENTS WITH HEMOPHILIA A - AN INTERNATIONAL OBSERVATIONAL STUDY
  Volume: 104 Page(s): 20 - 20
  09/09/2019 Authors: Escuriola-Ettinghausen C; Sidonio RF; Oldenburg J; Pezeshkpoor B; Mueller J; Konkle BA; Meeks SL; Dargaud Y; Pavlova A; Young G
• Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis.
  Haemophilia Volume: 25 Page(s): 789 - 796
  09/01/2019 Authors: Batsuli G; Zimowski KL; Tickle K; Meeks SL; Sidonio RF
• Is the comprehensive assessment tool of challenges in hemophilia (CATCH) appropriate to measure the impact of hemophilia and its treatment? First quantitative survey
  Volume: 25 Page(s): 59 - 60
  07/01/2019 Authors: Regnault A; Raimundo K; Patel A; Markowitz J; Marquis P; Shapiro A; Konkle B; Trask P; Ciesluk A; Rice M
• Development and implementation of an acute heavy menstrual bleeding protocol: a 2-year experience at a large pediatric academic institution
  Volume: 25 Page(s): 14 - 15
  07/01/2019 Authors: Brown M; White M; Sidonio R
• Analysis of patient bleeding and treatment patterns before and after von Willebrand disease diagnosis using data from a US medical claims database
  Volume: 25 Page(s): 60 - 61
  07/01/2019 Authors: Roberts J; Malec L; Halari I; Hale S; Oladapo A; Sidonio R
• Awareness, care, and treatment in obesity management to inform hemophilia obesity patient empowerment (ACTION-TO-HOPE): Results of a survey of United States hemophilia treatment center professionals
  Volume: 25 Page(s): 70 - 71
  07/01/2019 Authors: Wang M; Peltier S; Baumann K; Sidonio R; Witkop M; Cooper D; Waters E; Kahan S
• Sexual quality of life in women with congenital bleeding disorders
  Volume: 25 Page(s): 37 - 37
  07/01/2019 Authors: Kulshreshtha A; Hastie E; Zia A; Sidonio R
• Aberrant splicing contributes to severe -spectrin-linked congenital hemolytic anemia.
  J Clin Invest Volume: 129 Page(s): 2878 - 2887
  04/30/2019 Authors: Gallagher PG; Maksimova Y; Lezon-Geyda K; Newburger PE; Medeiros D; Hanson RD; Rothman J; Israels S; Wall DA; Sidonio RF
• Modern treatment of inhibitor-positive patients with haemophilia A (motivate)-an international observational study
  Volume: 25 Page(s): 64 - 65
  02/01/2019 Authors: Escuriola-Ettingshausen C; Sidonio RF
• Correlations between patient-reported outcomes and self-reported characteristics in adults with hemophilia B and caregivers of children with hemophilia B: analysis of the B-HERO-S study.
  Patient Relat Outcome Meas Volume: 10 Page(s): 299 - 314
  01/01/2019 Authors: Buckner TW; Sidonio R; Witkop M; Guelcher C; Cutter S; Iyer NN; Cooper DL
• Reliability and validity of patient-reported outcome instruments in US adults with hemophilia B and caregivers in the B-HERO-S study.
  Eur J Haematol Volume: 101 Page(s): 781 - 790
  12/01/2018 Authors: Buckner TW; Sidonio R; Guelcher C; Kessler CM; Witkop M; Clark D; Owens W; Fridman M; Iyer NN; Cooper DL
• Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States
  Volume: 132
  11/29/2018 Authors: Malec LM; Witmer CM; Jaffray J; Kouides PA; Haley KM; Sidonio RF; Cheng D; Abshire TC; White GC; Ragni MV
• Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program
  Volume: 132
  11/29/2018 Authors: Flood VH; Christopherson PA; Gill JC; Friedman KD; Haberichter SL; Di Paola J; James PD; Journeycake JM; Lentz SR; Leissinger CA
• Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis
  Volume: 132
  11/29/2018 Authors: Zimowski KL; Batsuli GM; Reding MT; Rana J; Callaghan MU; Tickle K; Meeks SL; Sidonio RF
• A cross-sectional study of non-attendance among patients at a US hemophilia treatment center 2010-2014.
  Haemophilia Volume: 24 Page(s): 902 - 910
  11/01/2018 Authors: Barry V; Steffens C; Mattis S; Sidonio RF; Tran DQ; Kempton CL
• A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding.
  Blood Adv Volume: 2 Page(s): 2629 - 2636
  10/23/2018 Authors: Candy V; Whitworth H; Grabell J; Thibeault L; Harpell L; Bowman M; Good D; Hopman WM; Sidonio RF; James PD
• Acquired Hypofibrinogenemia Before Asparaginase Exposure During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report of 2 Cases and Review of the Literature.
  J Pediatr Hematol Oncol Volume: 40 Page(s): e470 - e472
  10/01/2018 Authors: Raikar SS; Felker J; Patel KN; Lew G; Sidonio RF
• Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States.
  J Med Econ Volume: 21 Page(s): 762 - 769
  08/01/2018 Authors: Neufeld EJ; Sidonio RF; O'Day K; Runken MC; Meyer K; Spears J
• Novel therapeutics for hemophilia and other bleeding disorders.
  Blood Volume: 132 Page(s): 23 - 30
  07/05/2018 Authors: Callaghan MU; Sidonio R; Pipe SW
• Impact of hemophilia B on quality of life in affected men, women, and caregivers-Assessment of patient-reported outcomes in the B-HERO-S study.
  Eur J Haematol Volume: 100 Page(s): 592 - 602
  06/01/2018 Authors: Buckner TW; Witkop M; Guelcher C; Sidonio R; Kessler CM; Clark DB; Owens W; Frick N; Iyer NN; Cooper DL
• ETHICAL DECISION MAKING FRAMEWORK IN PREVIOUSLY UNTREATED SEVERE HEMOPHILIA A PATIENTS
  Volume: 65
  06/01/2018 Authors: Lanzel AF; Soucie JM; Ortmann L; Barrett D; Sidonio R; Meeks S
• Relevance of Abusive Head Trauma to Intracranial Hemorrhages and Bleeding Disorders.
  Pediatrics Volume: 141
  05/01/2018 Authors: Anderst JD; Carpenter SL; Presley R; Berkoff MC; Wheeler AP; Sidonio RF; Soucie JM
• Long-term outcomes of patients with severe hemophilia A and high titer inhibitors with partial tolerance after immune tolerance induction
  Volume: 24 Page(s): 48 - 49
  05/01/2018 Authors: Batsuli G; Meeks S; Sidonio R
• Management and outcomes of heavy menstrual bleeding in adolescents with bleeding disorders
  Volume: 24 Page(s): 195 - 195
  05/01/2018 Authors: White M; Kumpf P; Sidonio R; Patel K; Tickle K
• HAVEN 2 Updated Analysis: Multicentre, Open-label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Paediatric Patients with Haemophilia A with Inhibitors
  Volume: 181 Page(s): 20 - 21
  04/01/2018 Authors: Young G; Sidonio RF; Liesner R; Oldenburg J; Chang T; Uguen M; Dhalluin C; Schmitt C; Levy GG; Shima M
• The spectrum of bleeding in women and girls with haemophilia B.
  Haemophilia Volume: 24 Page(s): 180 - 185
  03/01/2018 Authors: Staber J; Croteau SE; Davis J; Grabowski EF; Kouides P; Sidonio RF
• Development of a Concept-Driven Disease Impact Instrument from Patients with Hemophilia (Pediatric and Adult) and Caregivers
  Volume: 130
  12/07/2017 Authors: Markowitz JT; Ma E; Solari P; Marquis P; Shapiro AD; Konkle B; Trask P; Pezalla E; Christian A; Rice M
• US Economic Impact of Recombinant FVIII Vs Plasma-Derived FVIII/VWF in Previously Untreated Hemophilia a Patients
  Volume: 130
  12/07/2017 Authors: Sidonio RF; Runken MC; O'Day K; Meyer K; Spears J
• Radionuclide synovectomy/synoviorthesis (RS) in patients with bleeding disorders: A review of patient and procedure demographics and functional outcomes in the ATHNdataset.
  Haemophilia Volume: 23 Page(s): 926 - 933
  11/01/2017 Authors: McGuinn C; Cheng D; Aschman D; Carpenter SL; Sidonio R; Soni A; Tarantino MD; Wheeler AP; Dunn AL; ATHN3 Working Group
• Impact of diagnosis of von Willebrand disease on patient outcomes: Analysis of medical insurance claims data.
  Haemophilia Volume: 23 Page(s): 743 - 749
  09/01/2017 Authors: Sidonio RF; Haley KM; Fallaize D
• Radionuclide synovectomy/synoviorthesis (RS) in persons with bleeding disorders: A review of impact of national guidance on frequency of RS using the ATHNdataset.
  Haemophilia Volume: 23 Page(s): e385 - e388
  07/01/2017 Authors: Sharma R; Dunn A; Aschman D; Cheng D; Wheeler A; Soni A; McGuinn C; Knoll C; Stein DT; Young G
• von Willebrand disease Outreach into Integrated Care Education (VOICE): a call to action.
  Haemophilia Volume: 23 Page(s): e370 - e373
  07/01/2017 Authors: Wang M; Konkle BA; Sidonio RF; Flood V; Koenig C; Kulkarni R
• Characterization of Hysterectomy/Uterine Ablation Rates in VWD and Undiagnosed Bleeding Using Claims Data
  Volume: 129 Page(s): 79S - 80S
  05/01/2017 Authors: Sidonio RF; Woods K; Fallaize D
• Evaluation of the Response to Desmopressin in Hemophilia A Carriers and Normal Controls: Preliminary Results
  Volume: 23 Page(s): 8 - 10
  04/01/2017 Authors: Candy V; Grabell J; Thibeault L; Harpell L; Bowman M; Good D; Sidonio R; James P
• Evaluating the psychosocial impact of hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.
  Eur J Haematol Volume: 98 Suppl 86 Page(s): 3 - 4
  04/01/2017 Authors: Sidonio R; Holot N; Cooper DL
• Management of US men, women, and children with hemophilia and methods and demographics of the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.
  Eur J Haematol Volume: 98 Suppl 86 Page(s): 5 - 17
  04/01/2017 Authors: Buckner TW; Witkop M; Guelcher C; Frey MJ; Hunter S; Peltier S; Recht M; Walsh C; Kessler CM; Owens W
• Radionuclide synovectomy in patients with bleeding disorders: a review of malignancy and myeloproliferative neoplasms from the ATHNdataset.
  Haemophilia Volume: 23 Page(s): e160 - e162
  03/01/2017 Authors: Lim MY; Cheng D; Aschman D; Dunn A; ATHN3 Working Group
• REPORTED BLEEDING AMONG FEMALES WITH FVIII OR FIX DEFICIENCY AND TYPE 1 VON WILLEBRAND DISEASE: RESULTS FROM THE FEMALE UDC
  AMERICAN JOURNAL OF HEMATOLOGY Volume: 91 Page(s): E420 - E420
  09/01/2016 Authors: Sidonio RF; Barry V; Byams V; Debaun M; Lollar J
• Management of US Boys and Girls with Hemophilia B: Caregiver Insights from the Bridging Hemophilia B Experiences Results Opportunities into Solutions (B-HERO-S) Study
  HAEMOPHILIA Volume: 22 Page(s): 126 - 126
  07/01/2016 Authors: Guelcher C; Recht M; Frey M; Sidonio R; Rice M; Haugstad K; Holot N; Cooper DL
• Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia.
  J Pediatr Surg Volume: 51 Page(s): 122 - 127
  01/01/2016 Authors: Englum BR; Rothman J; Leonard S; Reiter A; Thornburg C; Brindle M; Wright N; Heeney MM; Jason Smithers C; Brown RL
• One-Stage FVIII Activity Is Inversely Correlated with Heavy Menstrual Bleeding in Hemophilia a Carriers
  Volume: 126
  12/03/2015 Authors: Sidonio RF; Meeks SL; Whitworth HB
• Haemophilia A carriers experience reduced health-related quality of life.
  Haemophilia Volume: 21 Page(s): 761 - 765
  11/01/2015 Authors: Gilbert L; Paroskie A; Gailani D; Debaun MR; Sidonio RF
• A cross-sectional study of bleeding phenotype in haemophilia A carriers.
  Br J Haematol Volume: 170 Page(s): 223 - 228
  07/01/2015 Authors: Paroskie A; Gailani D; DeBaun MR; Sidonio RF
• Niacin has limited effectiveness in reduction of elevated lipoprotein(A) in children with or at risk of thrombosis or stroke
  Volume: 13 Page(s): 936 - 937
  06/01/2015 Authors: Patel K; Swerdlin R; Sidonio R
• Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry.
  Am J Hematol Volume: 90 Page(s): 187 - 192
  03/01/2015 Authors: Rice HE; Englum BR; Rothman J; Leonard S; Reiter A; Thornburg C; Brindle M; Wright N; Heeney MM; Smithers C
• New developments in pediatric venous thromboembolism and anticoagulation, including the target-specific oral anticoagulants.
  Curr Opin Pediatr Volume: 27 Page(s): 18 - 25
  02/01/2015 Authors: Lyle CA; Sidonio RF; Goldenberg NA
• The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life.
  Pediatr Crit Care Med Volume: 16 Page(s): 66 - 74
  01/01/2015 Authors: Northrop MS; Sidonio RF; Phillips SE; Smith AH; Daphne HC; Pietsch JB; Bridges BC
• Management of VWD.
  Hematology Am Soc Hematol Educ Program Volume: 2014 Page(s): 536 - 541
  12/05/2014 Authors: Neff AT; Sidonio RF
• A two-center retrospective review of the hematologic evaluation and laboratory abnormalities in suspected victims of non-accidental injury.
  Child Abuse Negl Volume: 38 Page(s): 1794 - 1800
  11/01/2014 Authors: Paroskie A; Carpenter SL; Lowen DE; Anderst J; DeBaun MR; Sidonio RF
• Haemophilia A carriers demonstrate pathological and radiological evidence of structural joint changes.
  Haemophilia Volume: 20 Page(s): e426 - e429
  11/01/2014 Authors: Gilbert L; Rollins L; Hilmes M; Luo Y; Gailani D; Debaun MR; Sidonio RF
• Three cost-utility analyses of screening for intracranial hemorrhage in neonates with hemophilia.
  J Pediatr Hematol Oncol Volume: 36 Page(s): 474 - 479
  08/01/2014 Authors: Malec LM; Sidonio RF; Smith KJ; Cooper JD
• Females with FVIII and FIX deficiency have reduced joint range of motion.
  Am J Hematol Volume: 89 Page(s): 831 - 836
  08/01/2014 Authors: Sidonio RF; Mili FD; Li T; Miller CH; Hooper WC; DeBaun MR; Soucie M; Hemophilia Treatment Centers Network
• Rise in late onset vitamin K deficiency bleeding in young infants because of omission or refusal of prophylaxis at birth.
  Pediatr Neurol Volume: 50 Page(s): 564 - 568
  06/01/2014 Authors: Schulte R; Jordan LC; Morad A; Naftel RP; Wellons JC; Sidonio R
• The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population.
  Br J Haematol Volume: 165 Page(s): 832 - 835
  06/01/2014 Authors: Vear SI; Ayers GD; Van Driest SL; Sidonio RF; Stein CM; Ho RH
• HEMOPHILIA A CARRIERS WITH NORMAL FACTOR ACTIVITY DEMONSTRATE CLINICAL AND RADIOLOGIC EVIDENCE OF STRUCTURAL JOINT CHANGES
  AMERICAN JOURNAL OF HEMATOLOGY Volume: 89 Page(s): E36 - E36
  06/01/2014 Authors: Gilbert L; Rollins L; Hilmes M; Luo Y; Gailani D; Debaun M; Sidonio R
• Both hemophilia health care providers and hemophilia a carriers report that carriers have excessive bleeding.
  J Pediatr Hematol Oncol Volume: 36 Page(s): e224 - e230
  05/01/2014 Authors: Paroskie A; Oso O; Almassi B; DeBaun MR; Sidonio RF
• Notes from the field: late vitamin K deficiency bleeding in infants whose parents declined vitamin K prophylaxis--Tennessee, 2013.
  MMWR Morb Mortal Wkly Rep Volume: 62 Page(s): 901 - 902
  11/15/2013 Authors: Centers for Disease Control and Prevention (CDC)
• Late Vitamin K Deficiency Bleeding in Infants Whose Parents Declined Vitamin K Prophylaxis - Tennessee, 2013
  MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT Volume: 62 Page(s): 901 - 902
  11/15/2013 Authors: Warren M; Miller A; Traylor J; Sidonio R; Morad A; Goodman A; Christensen D; Grant A; Odom E; Okoroh E
• Females With FVIII Deficiency Have Reduced Mean Overall Joint Range Of Motion
  Volume: 122
  11/15/2013 Authors: Sidonio RF; Mili F; Li T; Miller CH; Hooper WC; DeBaun MR; Soucie JM
• Idiopathic myelofibrosis in children: primary myelofibrosis, essential thrombocythemia, or transient process?
  J Pediatr Hematol Oncol Volume: 35 Page(s): 559 - 565
  10/01/2013 Authors: Slone JS; Smith MC; Seegmiller AC; Sidonio RF; Yang E
• Exploring barriers and facilitators to clinical trial enrollment in the context of sickle cell anemia and hydroxyurea.
  Pediatr Blood Cancer Volume: 60 Page(s): 1333 - 1337
  08/01/2013 Authors: Lebensburger JD; Sidonio RF; Debaun MR; Safford MM; Howard TH; Scarinci IC
• Retrospective Review of Hematologic Evaluation in Children with Suspected Non-Accidental Injury, A First Step towards Evidence Based Guidelines
  Volume: 120
  11/16/2012 Authors: Paroskie A; Carpenter S; Lowen D; Anderst J; DeBaun MR; Sidonio RF
• Discordance in Provider Practice Patterns and Hemophilia A Carrier Health Care Preferences
  Volume: 120
  11/16/2012 Authors: Paroskie A; Ooso O; Almassi B; DeBaun MR; Sidonio RF
• ACQUIRED FACTOR XIII DEFICIENCY IN AN 18 YEAR OLD FEMALE
  PEDIATRIC BLOOD & CANCER Volume: 58 Page(s): 1036 - 1036
  07/01/2012 Authors: Paroskie A; Sidonio R; Gailani D
• Predictors of von Willebrand disease in children.
  Pediatr Blood Cancer Volume: 58 Page(s): 736 - 740
  05/01/2012 Authors: Sidonio RF; Gunawardena S; Shaw PH; Ragni M
• Screening for von Willebrand disease in children: a case-control study.
  J Thromb Haemost Volume: 9 Page(s): 1086 - 1089
  05/01/2011 Authors: Bujnicki HC; Sidonio RF; Kempton C; Kouides PA; Kulkarni R; Nugent DJ; Yee DL; Moore CG; Ragni MV
• Factor VIII Intron 22 Inversion Screening of Newborn Males for Hemophilia A: A Cost-Effectiveness Study
  Volume: 116 Page(s): 324 - 324
  11/19/2010 Authors: Luiza JW; Ragni MV; Sidonio RF; Smith KJ
• Predictors of Von Willebrand Disease In Children: A Case-Control Study
  Volume: 116 Page(s): 314 - 314
  11/19/2010 Authors: Bujnicki HL; Sidonio RF; Moore CG; Kempton CL; Kouides PA; Kulkarni R; Nugent DJ; Yee DL; Ragni MV
• Cost-utility analysis of von Willebrand disease screening in adolescents with menorrhagia.
  J Pediatr Volume: 157 Page(s): 456 - 460.e1
  09/01/2010 Authors: Sidonio RF; Smith KJ; Ragni MV
• COST-UTILITY ANALYSIS OF VON WILLEBRAND DISEASE SCREENING IN ADOLESCENTS WITH MENORRHAGIA
  PEDIATRIC BLOOD & CANCER Volume: 54 Page(s): 805 - 805
  06/01/2010 Authors: Sidonio R; Smith KJ; Ragni MV
• A COST-UTILITY ANALYSIS OF CRANIAL IMAGING IN NEONATES WITH HEMOPHILIA
  PEDIATRIC BLOOD & CANCER Volume: 54 Page(s): 806 - 806
  06/01/2010 Authors: Malec L; Sidonio R; Cooper J
• Cost-Utility Analysis of Von Willebrand Disease Screening in Adolescents with Menorrhagia
  Volume: 114 Page(s): 976 - 976
  11/20/2009 Authors: Sidonio RF; Smith KJ; Ragni MV
• PREDICTORS OF BLEEDING DISORDERS IN CHILDREN: A SINGLE INSTITUTION'S EXPERIENCE
  PEDIATRIC BLOOD & CANCER Volume: 52 Page(s): 711 - 711
  06/01/2009 Authors: Sidonio R; Shaw PH; Gunawardena S
• Successful combination therapy of a proximal haemophilic pseudotumour with surgery, radiation and embolization in a child with mild haemophilia A.
  Haemophilia Volume: 13 Page(s): 209 - 212
  03/01/2007 Authors: Ahuja SP; Sidonio R; Raj AB; Bertolone SJ; Silverman C; Antekeier DP; Fallat ME
• Human osteoclast differentiation is regulated by cell or serum factors in addition to CSF-1 and RANKL.
  JOURNAL OF BONE AND MINERAL RESEARCH Volume: 15 Page(s): S513 - S513
  09/01/2000 Authors: Blair H; Dong S; Sidonio R; Friedburg R; Schlesinger P
• Proteinase expression during differentiation of human osteoclasts in vitro.
  J Cell Biochem Volume: 78 Page(s): 627 - 637
  06/12/2000 Authors: Blair HC; Sidonio RF; Friedberg RC; Khan NN; Dong SS
• Mast cell disease in hyperparathyroid bone: Stem cell factor (c-kit ligand) promoter responds to PTH but not 1,25(OH)(2)D-3 in PTH-responsive osteoblast-like cells.
  JOURNAL OF BONE AND MINERAL RESEARCH Volume: 14 Page(s): S445 - S445
  09/01/1999 Authors: Blair HC; Cao X; Shi X; Sidonio RF; Dong SS